Original article: cardiovascularPretreatment with angiotensin-converting enzyme inhibitors attenuates ischemia-reperfusion injury
Section snippets
Randomization
Twenty pigs were entered into the study and none were excluded. Animals were fed a standard chow diet to which either quinapril (20 mg PO q.d.) or a placebo were added for 1 week. They were randomized by selecting a sealed envelope, which contained a 7-day supply of medication, such that the investigators were blinded to the identity of the medication.
Preparation
Adult pigs (35 to 38 kg) were premedicated with ketamine (15 mg/kg intramuscularly [IM]) and xylazine (0.5 mg/kg IM), anesthetized with
Hemodynamic parameters during coronary occlusion prior to CPB
Table 1 summarizes the changes in hemodynamics during the 90 minutes of coronary occlusion prior to CPB. There was no significant difference in heart rate, MAP, or LVEDP between quinapril and non-ACE inhibitor animals prior to coronary occlusion. Following 90 minutes of coronary occlusion, both groups showed small, but significant (p < 0.05) decreases in heart rate and MAP from preischemic values, although there was no difference between the quinapril and no-ACE inhibitor groups. LVEDP was
Comment
Previous studies have shown that ACE inhibitors may play an important role in minimizing ischemic events during and following CABG surgery 5, 6, 7. The results of this study indicate that they may also play an important role in preventing myocardial injury when given prior to surgery.
The beneficial effects of ACE inhibitors following CABG were reported in two clinical trials involving high tissue affinity ACE inhibitors 5, 6. In the QUOVADIS (Quinapril on Vascular ACE and Determinants of
Acknowledgements
This work was supported in part by a grant from Pfizer Pharmaceuticals Inc, New York, NY.
References (21)
- et al.
Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic decrease?
J Am Coll Cardiol
(2001) - et al.
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
Lancet
(1992) - et al.
Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUOVADIS study) Am J Cardiol
(2001) - et al.
The angiotensin-converting enzyme inhibition post revascularization study (APRES)
J Am Coll Cardiol
(2000) - et al.
Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements
Br J Anaesth
(1999) - et al.
Beneficial effects of ramipril on left ventricular end-diastolic and end-systolic volume indexes after uncomplicated invasive revascularization are associated with a reduction in cardiac events in patients with moderately impaired left ventricular and no clinical heart failure
J Am Coll Cardiol
(2001) - et al.
Counteraction of the vasodilator effect of enalapril by aspirin in severe heart failure
J Am Coll Cardiol
(1992) - et al.
Clinical effects of early angiotension-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin
J Am Coll Cardiol
(2000) Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
N Engl J Med
(2000)- et al.
Effects of captopril on ischemic events after myocardial infarctionresults of the Survival and Ventricular Enlargement trial
Circulation
(1994)